1Schiller J H,Harrington D,Belani C P,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J].N Engl J Med,2002,346:92-98.
2Jemal A,Tiwari R C,Murray T,et al.Cancer statistics,2004[J].CA Cancer J Clin,2004,54:8-29.
3Lynch T J,Bell D W,Sordella R,et al.Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J].N Engl J Med,2004,350(21):2129-2139.
4Leon S A,Shapiro B,Sklaroff D M,et al.Free DNA in the serum of cancer patients and the effect of therapy[J].Cancer Res,1977,37:646-650.
5Bendich A,Wilczok T,Borenfreund E.Circulating DNA as a possible factor in oncogenesis[J].Science,1965,148:374.
6Holdenrieder S,Stieber P,Bodenmüller H,et al.Nucleosomes in serum as a marker for cell death[J].Clinical Chemistry and Laboratory Medicine,2001,39(7):596-605.
7Trejo-Becerril C,Perez-Cardenas E,Trevino-Cuevas H,et al.Circulating nucleosomes and response to chemotherapy:an in vitro,in vivo and clinical study on cervical cancer patients[J].Int J Cancer,2003,104(6):663-668.
8Roman M,Micha B,Carmella C,et al.Mismatch repair genes and microsatellite instability as molecular markers for gynecological cancer detection[J].Experimental Biology and Medicine,2002,227:579-586.
9Shao Z M,Nguyen M.Tumor-specific DNA in plasma of breast cancer patients[J].Anti-cancer Drugs,2002,13 (4):353-357.
10Holdenrieder S,Stieber P,Forg T,et al.Apoptosis in serum of patients with solid tumours[J].Anticancer Res,1999,19(4A):2721-2724.
